Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000422317

Medchemexpress LLC Exendin-3/4 (59-86) Pedin-3/4 (59-86 | 1263874-37-8 | 98.2% | 3055.42 | 5 MG
SDP

Catalog No. 5000422317
Encompass_Preferred

Exendin-3/4 (59-86) is a derivative of Exendin-4 peptide. Exendin-4 itself is a pure GLP-1 receptor agonist. Exendin-4 peptide derivatives are structurally derived from Exendin-4 and may be related to dual GLP-1/glucagon receptor agonists.

  • Peptide derivative.
  • Structurally derived from Exendin-4.
  • May relate to dual GLP-1/glucagon receptor agonists.
  • Potential medical use in treating disorders of the metabolic syndrome, including diabetes and obesity.
  • May help with the reduction of excess food intake.
  • Shows reduced activity on the GIP receptor, which may lower the risk of hypoglycemia.

Catalog No. 50-004-22317 Supplier Medchemexpress LLC Supplier No. HYP12235MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Exendin-3/4 (59-86) is a derivative of Exendin-4 peptide. Exendin-4 itself is a pure GLP-1 receptor agonist. Exendin-4 peptide derivatives are structurally derived from Exendin-4 and may be related to dual GLP-1/glucagon receptor agonists.

  • Peptide derivative.
  • Structurally derived from Exendin-4.
  • May relate to dual GLP-1/glucagon receptor agonists.
  • Potential medical use in treating disorders of the metabolic syndrome, including diabetes and obesity.
  • May help with the reduction of excess food intake.
  • Shows reduced activity on the GIP receptor, which may lower the risk of hypoglycemia.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.